You are here

IDX20963

Why Idenix Could Rise Even Higher, and Challenge Gilead and Vertex

Yahoo/24-7 Wallstreet

Sat, 11/2/13 - 11:27 am

Three Future Winners and One Major Loser in the HCV Wars

Motley Fool

Fri, 07/19/13 - 11:38 am

Bristol-Myers Squibb

This Week in Biotech

Motley Fool

Sun, 06/23/13 - 11:11 am

pain management

prostage cancer

Why Idenix Pharmaceuticals Shares Were Put in Time-Out Again

Motley Fool

Sat, 06/22/13 - 09:46 am

Idenix says FDA wants more safety data on experimental hepatitis C drug, delaying human trials

Yahoo/AP

Fri, 06/21/13 - 09:16 am